Bio Protocol vs SKALE — how do they compare? Bio Protocol trades at Rp515.61 (market cap Rp1,15T, Rp260,42M 24h volume), while SKALE trades at Rp78.15 (market cap Rp480,97M, Rp226,13M 24h volume). The key difference: Bio Protocol is far larger — about 2391× SKALE's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 6,2B / 7B SKL (89%) for SKALE. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and SKALE for 18 Days on average.
| BIO | SKL | |
|---|---|---|
Market Cap | Rp1,15T | Rp480,97M |
Volume (24h) | Rp260,42M | Rp226,13M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 6,2B / 7B SKL (89%) |
Typical Hold Time | 16 Days | 18 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
SKALE (SKL) trades at Rp78.124 with a market cap of Rp481.49M, showing bullish technical signals from moving averages and strong trend strength per ADX. The token is near its pivot point of Rp82, with support at Rp77 and resistance at Rp86. No major protocol updates or ecosystem news are reported recently, keeping fundamental developments quiet.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential overbought conditions. Key opportunities lie in breaking resistance for upward momentum, while major risks involve low liquidity and crypto market sentiment shifts.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →SKALE is a blockchain network built to support decentralized applications (dApps) with zero gas fees, high speed, and unlimited scalability. It consists of EVM-compatible Layer 1 blockchains, called SKALE Chains, which can be dedicated to a single dApp or shared among multiple dApps. These modular chains provide pooled security, dynamic scaling, and flexible resource allocation, making dApp deployment more efficient and user-friendly.
Read more on SKL →